GeneBioTech Co. ,Ltd

₩4,935As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:086060Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (0.06%)
Div yield 1.01%
ROE 6.72%
Pharmaceutical Preparations
Beta (5Y) 0.18
PE TTM 11.57
TSR TTM 27.24%
Mkt cap ₩42.49B
ROIC 8.61%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩4,745
(3.86%)
(92.12%)
Sell 1|5|3|0|1
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
55.67
54.14
56.92
55.52
19.29%
16.76%
19.62%
10.96%
Revenue₩B
4.604
4.689
4.866
4.878
14.41%
11.45%
13.78%
9.97%
Peers (US$31.33M)
Cap (US$)
PE
33.23M
6.691x
33.17M
—
30.25M
14.38x
Capital
TTM
5Y
10Y
Leveragex
1.467
—
—
EBIT/Intx
4.326
0.078
0.077
Own earn%
(67.42)
(119.37)
(120.87)
Sh yield%
14.68
34.94
38.53
Owners
Insiders/Inst%
13.79
84.96
Short interest%
1.04
SBC / revenue%
2.64
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
3–8
$1 testx
−0.2
Incr. ROIC%
47